Patents Assigned to Mindset Biopharmaceuticals (USA)
  • Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
    Publication number: 20020086847
    Abstract: DNA encoding a recombinant antibody molecule end-specific for an amyloid-&bgr; peptide, pharmaceutical compositions thereof, and a method for preventing the accumulation of amyloid-&bgr; peptides in the extracellular milieu of neurons by causing an end-specific antibody to come into contact with such amyloid-&bgr; peptides. Such a method is useful for preventing or inhibiting progression of Alzheimer's Disease.
    Type: Application
    Filed: October 15, 2001
    Publication date: July 4, 2002
    Applicant: Mindset Biopharmaceuticals (USA)
    Inventor: Daniel G. Chain